DR. STUART WEG, M.D.
Anesthesiologist Assistant at 2 Ave, New York, NY
License number
New York 1402201
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
2
800 2Nd Ave SUITE 900, New York, NY 10017
498 Island Way, Franklin Lakes, NJ 07417
498 Island Way, Franklin Lakes, NJ 07417
Phone
(212) 679-9667
(212) 901-2134 (Fax)
(551) 427-2398
(201) 848-1805 (Fax)
(212) 901-2134 (Fax)
(551) 427-2398
(201) 848-1805 (Fax)
Organization information
See more information about STUART WEG at bizstanding.comStuart Weg MD
498 Is Way, Franklin Lakes, NJ 07417
Industry:
Anesthesiologist Specializing In Pain Management, Anesthesiology
Doing business as:
Pain Relief Trtmnt Specialists
Phone:
(201) 848-9344 (Phone)
Interior Designers:
Stuart L. Weg (Owner),Elaine Zagha Weg (Interior Designer)
Professional information
Anesthetic Composition, Formulation And Method Of Use
US Patent:
2009014, Jun 4, 2009
Filed:
Nov 6, 2008
Appl. No.:
12/291343
Inventors:
Stuart L. Weg - Franklin Lakes NJ, US
International Classification:
A61K 31/167, A61K 31/445, A61P 23/00
US Classification:
514330, 514626
Abstract:
An anesthetic composition for use e.g. in the administration of a local anesthetic by injection comprises a first component, which comprises hyaluronidase, and a second component which comprises an anesthetic preparation. The composition is both effective and highly shelf stable, and has as an advantage that it may be stored and administered at room temperature. In a particular embodiment, the hyaluronidase is prepared in dry powder form, as by lyophilization. The anesthetic component may be selected from a group of known anesthetics, such as lidocaine, polocaine, xylocaine, novocaine, procaine, prilocaine, bupivacaine, mepivacaine, carbocaine, etidocaine and chincocaine. The composition may be prepared in unit dosage forms, including a single dosage form, for a variety of purposes, and such unit dosage forms may be prepared in a plural chambered syringe or like dispenser, whereby the components are not mixed until administration.
Administration Of Ketamine For Detoxification And Treatment Of Tobacco Addiction
US Patent:
5679714, Oct 21, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/477365
Inventors:
Stuart L. Weg - Franklin Lakes NJ
International Classification:
A61K 31135
US Classification:
514647
Abstract:
The present invention is directed to a method for treating substance addiction comprising administering ketamine in an amount effective to facilitate detoxification or assist in overcoming substance addiction, or both.
Anxiolytic Composition, Formulation And Method Of Use
US Patent:
2014005, Feb 27, 2014
Filed:
Aug 23, 2013
Appl. No.:
13/975060
Inventors:
Stuart WEG - Franklin Lakes NJ, US
International Classification:
A61K 31/135
US Classification:
514647
Abstract:
A method for treating, ameliorating or preventing the onset of anxiety in a subject comprises administering to such subject an NMDA receptor antagonist in an amount that is sub-anesthetic and hypo-analgetic. The NMDA receptor antagonist may comprise ketamine and its pharmaceutically acceptable salts, and is administered as a premedication. Instances of use in this manner include administration prior to an anxiety causing event, such as a medical or a dental procedure. The administration of the NMDA receptor antagonist composition is particularly useful as a premedication for adults.
Administration Of Ketamine To Manage Pain And To Reduce Drug Dependency
US Patent:
6248789, Jun 19, 2001
Filed:
Feb 27, 1998
Appl. No.:
9/029146
Inventors:
Stuart L. Weg - Franklin Lakes NJ
International Classification:
A61K 31135
US Classification:
514647
Abstract:
The present invention is directed to the transmucosal, transdermal or oral administration of ketamine, either alone or in combination with other pain medications, to manage and treat pain and to reduce drug dependency in a subject.
Use Of Antifungal Compositions To Treat Upper Gastrointestinal Conditions
US Patent:
2012032, Dec 27, 2012
Filed:
Mar 22, 2012
Appl. No.:
13/427034
Inventors:
Stuart L. Weg - Franklin Lakes NJ, US
International Classification:
A61K 31/7048, A61P 1/02, A61P 1/04, A61P 1/08, A61P 1/00, A61P 31/10
US Classification:
514 31
Abstract:
The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms.
Use Of Antifungal Compositions To Treat Upper Gastrointestinal Conditions
US Patent:
2011000, Jan 13, 2011
Filed:
Aug 16, 2010
Appl. No.:
12/806564
Inventors:
Stuart L. Weg - Franklin Lakes NJ, US
International Classification:
A61K 35/74, A61K 31/7048, A61K 33/04, A61K 33/06, A61K 33/30, A61K 33/34, A61K 36/288, A61K 38/54, A61K 38/48, A61P 1/08, A61P 1/00, A61P 31/10, A61P 1/04, A61P 1/14, A61P 29/00, A61P 1/02
US Classification:
424 934, 514 31, 424702, 424682, 424643, 424630, 424764, 424 9421, 424 9465, 424 9466
Abstract:
The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms.
Use Of Antifungal Compositions To Treat Upper Gastrointestinal Conditions
US Patent:
7776831, Aug 17, 2010
Filed:
Jan 30, 2007
Appl. No.:
11/668764
Inventors:
Stuart L. Weg - Franklin Lakes NJ, US
International Classification:
A61K 31/70, A01N 43/04, C01B 31/34, C01B 21/22, C01B 21/24
US Classification:
514 31, 424440, 424400, 514 1
Abstract:
The present invention provides a novel method for treating oral conditions and upper gastrointestinal conditions in a subject by providing an inventive oral dosage form of a pharmaceutical composition comprising an effective amount of at least one antifungal and optionally a flavor modifier and/or salivation component such as an herbal component. In the present invention, the subjects have either not been diagnosed or do not have active or recurrent fungal infections. Specifically, the present invention is directed to chewable dosage forms.
Administration Of Ketamine For Detoxification And To Treat Substance Addiction, And Compositions Therefor
US Patent:
5989582, Nov 23, 1999
Filed:
Aug 14, 1997
Appl. No.:
8/894845
Inventors:
Stuart L. Weg - Franklin Lakes NJ
International Classification:
A61F 1302, A61K 4718
US Classification:
424434
Abstract:
A method to facilitate detoxification and treat substance addiction by administration of ketamine and a benzodiazepine. A preferred dosage range of ketamine is about 0. 01 mg/kg of body weight to about 1 mg/kg. Pharmaceutical compositions comprising this dosage range of ketamine in a gum or candy are also provided. In a specific example, a dedicated smoker was able to reduce her craving from three packs of cigarettes a day.
Nasal Administration Of Ketamine To Manage Pain
US Patent:
5543434, Aug 6, 1996
Filed:
Feb 25, 1994
Appl. No.:
8/201756
Inventors:
Stuart L. Weg - Franklin Lakes NJ
International Classification:
A61K 31135
US Classification:
514647
Abstract:
The invention relates to self-management of pain on an outpatient basis comprising administering via a nasal route a dose of ketamine effective to alleviate pain to a subject suffering from pain.